학술논문

A personalized medicine approach identifies enasidenib as an efficient treatment for IDH2 mutant chondrosarcoma
Document Type
Article
Source
In: eBioMedicine. (eBioMedicine, April 2024, 102)
Subject
Language
English
ISSN
23523964